Skip to content


Strength­ening our commitment to Deep Tech with a new $725m fund
Rocket Lab

When we started DCVC almost a decade ago, one of the pressing Deep Tech problems of the day was scale-out compute. Our firm played a role in creating some of the most important computing resources taken for granted today. Many of our team’s early investments became the building blocks of today’s computing giants including AWS, Microsoft Azure, Google Cloud, Illumina, and VMware. They also, in a very material way, enabled the large-scale machine-learning and AI capa­bil­i­ties upon which people are building the future.

Our early role has consis­tently given us unique access to scientists and engineers using these computing superpowers” to attack previously insur­mount­able problems far beyond IT. We saw that their solutions could upend — and were in fact already disrupting — global industries. Conse­quently, we believe the current Deep Tech opportunity is both immense and impactful, even relative to prior incarnations.

DCVC V — $725 million focused on a $20+ Trillion GDP Opportunity[1]

We are grateful that our success to date enabled us to close DCVC V, a new $725 million Deep Tech fund, our eighth overall. DCVC V will continue to back early-stage Deep Tech teams as well as doubling down on key later stage oppor­tu­ni­ties as they emerge from within our portfolio. This fund, roughly twice the size of our prior vintage of funds, is one of the largest raises to date for Deep Tech.

We recognize that solving tough global challenges requires a deep bench of talented individuals. To support our new efforts, we continue to strengthen our team. First, we promoted Kelly Chen, a principal at DCVC with a strong track record and deep under­standing of our investment thesis, to partner. Alan Cohen, formerly of Cisco, Nicira and Illumio, and Matt Michelsen, formerly an advisor to 8VC, have joined as partners, bringing with each of them multiple decades of hard-won experience. And Kate Reed joins us as VP of marketing and commu­ni­ca­tions to help our companies tell their important stories.

Increas­ingly over the last decade, the companies we fund have addressed a broader spectrum of global GDP with each successive year. With DCVC V, we are largely focused on disruption in the $20+ trillion of GDP of the global economy, not incremental change in the $3 trillion IT sector. DCVC V exemplifies the shared belief of our LPs, our team, and our co-investors – that venture capital is an essential catalyst to validate, prove, and deliver new tech­nolo­gies that civi­liza­tion now demands.

Business as usual is broken. We believe venture capital can actively help correct some of the excesses of capitalism while delivering strong returns. Venture capital can address many urgent global problems and turn them into profitable oppor­tu­ni­ties – while empowering more people, more equitably, than stay the course.” Our experience shows that success­fully tackling the hard, even terrifying, problems of the world, often in innovation-resistant industries, has potentially greater impact and returns than many would believe.

Backing the Next Great Industrial Giants

We back teams taking on the global economy’s hardest challenges with novel compu­ta­tional and engineering approaches. These innovative scientists, engineers and company builders are applying Deep Tech to create the next great industrial giants. And we’ve seen them do it – from rockets to robots, from molecular manu­fac­turing™ to microbes, and from applied AI to autonomous systems.

Below are key sectors DCVC V is investing in:

Our portfolio companies are trans­forming unsus­tain­able global manu­fac­turing, relieving an over­stressed global food supply, curing seemingly incurable diseases, defeating terrorists and criminals, and providing the tools and systems to massively accelerate human innovation overall. Just a few examples of these amazing companies include:

Pivot Bio – Displacing the $212 billion synthetic fertilizer industry with a microbial alternative that delivers higher crop yields, reduces dead zones from nitrogen run-off and limits envi­ron­mental pollution to modernize farming and improve food harvests. In over 11,000 field trials, farmers using the microbes saw nearly a 17 bushel per acre advantage over those using only synthetic nitrogen fertilizer.

Planet – Satellite imaging and analytics company founded by ex-NASA employees, using over 150 of its satellites in orbit and powerful AI to image every square inch of the Earth’s surface every day, making global change visible, accessible and actionable.

Zymergen – The world’s first industrial scale Molecular Manu­fac­turing™ company, uniting AI, robotic labs and proprietary insights into multiple classes of microor­gan­isms to deliver novel products and materials at global customer scale.

Atomwise – Algorithmic drug and new product discovery for pharma and agriculture companies with novel AI for atom-by-atom chemistry. Atomwise screens more than 10 million compounds every day and their AtomNet’ technology continues to outperform status quo tech­nolo­gies, identifying hit compounds up to 10,000X higher than the physical high-throughput screening methods it augments. They’ve closed over $6B in pharma deals in less than a year, more than any other AI company, and have partic­i­pated in multiple tropical disease collaborations.

Rocket Lab – Leading light capacity (sub-200kg) rocket startup. With multiple satellites success­fully launched to orbit, delivers a range of complete rocket systems and tech­nolo­gies for fast and low-cost payload deployment. Recently launched seven small satellites to low-Earth orbit on the company’s seventh flight. Rocket Lab plans to launch once per week at scale.

Recursion Phar­ma­ceu­ti­cals – Enabling drug discovery through large-scale math­e­mat­ical modeling, applying break­through AI and computer vision to understand the behavior of millions of human cells in parallel, every hour, every day. Have multiple, FDA-cleared inves­ti­ga­tional new drug (IND) appli­ca­tions underway, as well as a partnership with Takeda to evaluate and identify novel preclinical candidates for rare diseases.

Embark – Leading autonomous trucking company. Embark transforms the safety, efficiency and costs of the $1 trillion global long-haul trucking market with autonomous trucks capable of reasoning their way along the roads like human drivers, no expensive and laborious pre-mapping required.

Gro Intel­li­gence – The Bloomberg terminal and platform for agri­cul­tural data. Gro gives users access to vast amounts of global agri­cul­tural data and enables them to build predictive models so they can make better and faster decisions by quickly under­standing and predicting the factors that affect supply and demand of agricultural markets.

The world’s problems are daunting. But we truly believe, based on our experience and past success, that venture capital can address many of these urgent challenges, profitably and equitably. And we are excited to continue to create meaningful outcomes with DCVC V. Come join us!

[1] GDP opportunity based on data from the World Bank World Development Indicators, found here.

Related Content